Clinical Trials Browser

OTHER × Melanoma × Immunotherapy, Adoptive × Clear all

NCT02354690 2020-03-23

Vemurafenib and TIL Therapy for Metastatic Melanoma

Phase 1/2 Completed

13 enrolled 12 charts

Melanoma

NCT00324623 2012-11-20

Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic Melanoma

Phase 1 Completed

Melanoma